Abiopharma

Results of the general meeting dated 25.6.26

Share Buy Back - Daily Share Buy-Back Notice: Daily Share Buy-Back Notice

General Announcement: Reporting Share Repurchase form for Financial Management Purposes No.2

ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Directors Interest - Tan Yeow Khoon

Americans Look Beyond Savings to Turn Retirement Confidence Into Reality, BlackRock Survey Finds

WidePoint Named Single Awardee of the $3.1 Billion DHS CWMS 3.0 Contract

GoldMining Issues Mid-Year 2026 Shareholder Update

Carter’s and the Atlanta Dream Launch First-of-Its-Kind Partnership to Redefine Family Fandom in Atlanta

Apogee Enterprises Declares Quarterly Cash Dividend